Villadar, Eufemia R.

HRN: 23-51-93  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/09/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
08/09/2023
08/15/2023
IVT
1.5gms
Q8
Minimal Pleural Effussion Sec To Lung Ca
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: